Division of Endocrinology and Metabolism, University of Texas Southwestern Medical Center, 2001 Inwood Road, Dallas, TX 75235, USA.
Division of Endocrinology, Diabetes, and Nutrition, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55902, USA.
Endocrinol Metab Clin North Am. 2019 Jun;48(2):341-355. doi: 10.1016/j.ecl.2019.02.001. Epub 2019 Mar 23.
Transgender women often seek hormone therapy to attain feminine physical features congruent with their gender identity. The aim of feminizing hormone therapy (FHT) is to provide suppression of endogenous testosterone and to maintain estradiol levels within the normal female range. Overall, FHT is safe if provided under supervision of an experienced health care provider and has been shown to improve quality of life. Data on care of transgender women are scarce and high-quality evidence-based recommendations are lacking. This article aims to review the published literature on FHT and provide guidance to clinicians caring for transgender women.
跨性别女性通常寻求激素治疗以获得与自身性别认同相符的女性生理特征。女性化激素治疗(FHT)的目的是抑制内源性睾酮并将雌二醇水平维持在正常女性范围内。总体而言,如果在有经验的医疗保健提供者的监督下提供 FHT,则是安全的,并且已显示可以提高生活质量。关于跨性别女性护理的数据很少,缺乏高质量的循证建议。本文旨在回顾关于 FHT 的已发表文献,并为照顾跨性别女性的临床医生提供指导。